TIDMHIK
RNS Number : 2161B
Hikma Pharmaceuticals Plc
31 May 2023
Hikma Pharmaceuticals PLC - LTIP and EIP Awards
LONDON, 31 May 2023: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) (LEI: 549300BNS685UXH4JI75) announces that the
Remuneration Committee made the following conditional awards under
the Hikma Pharmaceuticals PLC 2023 Long Term Incentive Plan (the
"LTIP"); the 2014 Executive Incentive Plan (the "EIP") to Persons
Discharging Managerial Responsibility ("PDMR") of the Company. No
consideration was paid for the grant of the awards.
Awards under the LTIP were made on 30 May 2023 based on a price
of GBP18.43 per Ordinary Share (being the average mid-market
Ordinary Share price for the for the 5-working day period prior to
30 May 2023, in accordance with the LTIP rules) (the "LTIP
Awards"). The vesting of the LTIP Awards is subject to the
continued employment of the PDMRs, malus and clawback provisions
and the satisfaction of performance conditions set by the
Remuneration Committee of the Company. The LTIP Awards will
normally vest on the later of the third anniversary of the date of
grant and the determination of the performance conditions. The LTIP
Awards are then subject to an additional two-year holding
period.
Awards under the EIP were made on 30 May 2023 based on a price
of GBP15.15 per Ordinary Share (being the average mid-market
Ordinary Share price for the 30-day period prior to 31 December
2022, in accordance with the EIP rules) (the "EIP Awards"). All EIP
Awards are subject to malus and clawback provisions. EIP Element B
Awards will normally vest on the second anniversary of the date of
grant, subject to continued employment, and are then subject to an
additional three-year holding period. EIP Element C Awards will
normally vest on the third anniversary of the date of grant,
subject to continued employment, and are then subject to an
additional two-year holding period.
This notification is made under Article 19(1) of the EU Market
Abuse Regulation 596/2014 as it forms part of domestic law by
virtue of the European Union (Withdrawal) Act 2018 ("MAR"). The
information set out below is provided in accordance with the
requirements of Article 19(3) of MAR.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman and Chief Executive Officer
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 132,783 Shares
Nil EIP Award, Element B: 31,679 Shares
Nil EIP Award, Element C: 19,761 Shares
d) Aggregated information Price(s): nil
Volume(s): 184,223
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 105,233 Shares
Nil EIP Award, Element B: 36,171 Shares
Nil EIP Award, Element C: 20,650 Shares
d) Aggregated information Price(s): nil
Volume(s): 162,054
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 76,130 Shares
Nil EIP Award, Element B: 28,647 Shares
Nil EIP Award, Element C: 20,982 Shares
d) Aggregated information Price(s): nil
Volume(s): 125,759
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 74,699 Shares
Nil EIP Award, Element B: 28,833 Shares
Nil EIP Award, Element C: 22,209 Shares
d) Aggregated information Price(s): nil
Volume(s): 125,741
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 75,339 Shares
Nil EIP Award, Element B: 36,371 Shares
Nil EIP Award, Element C: 30,749 Shares
d) Aggregated information Price(s): nil
Volume(s): 142,459
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 50,301 Shares
Nil EIP Award, Element B: 18,836 Shares
Nil EIP Award, Element C: 13,796 Shares
d) Aggregated information Price(s): nil
Volume(s): 82,933
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Susan Ringdal
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 38,409 Shares
Nil EIP Award, Element B: 15,925 Shares
Nil EIP Award, Element C: 11,664 Shares
d) Aggregated information Price(s): nil
Volume(s): 65,998
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Brian Hoffmann
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 54,422 Shares
Nil EIP Award, Element B: 12,233 Shares
Nil EIP Award, Element C: 8,302 Shares
d) Aggregated information Price(s): nil
Volume(s): 74,957
e) Date of the transaction 30 May 2023
f) Place of the Outside a trading venue
transaction
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description Description: Ordinary shares of 10 pence each
of the financial (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
b) Nature of the Grant of awards under the LTIP and EIP.
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
Nil LTIP Award: 41,408 Shares
Nil EIP Award, Element B: 15,983 Shares
Nil EIP Award, Element C: 12,406 Shares
d) Aggregated information Price(s): nil
Volume(s): 69,797
e) Date of the 30 May 2023
transaction
f) Place of the Outside a trading venue
transaction
Helen Middlemist
Deputy Company Secretary
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBSGDUCBXDGXB
(END) Dow Jones Newswires
May 31, 2023 10:20 ET (14:20 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
